{"created":"2023-05-15T14:40:45.026991+00:00","id":55889,"links":{},"metadata":{"_buckets":{"deposit":"f370372c-a772-458e-83d3-2a98db3e583c"},"_deposit":{"created_by":1,"id":"55889","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"55889"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00055889","sets":["7"]},"author_link":["571916","571914","571915","571913"],"item_10004_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2011-11","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"HIMAC-136","bibliographicPageEnd":"30","bibliographicPageStart":"29","bibliographic_titles":[{"bibliographic_title":"放射線医学総合研究所重粒子線がん治療装置等共同利用研究報告書"}]}]},"item_10004_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The purpose of this study is to analyze the correlation between gastrointestina (GI) toxicities and dose-volume factors of carbon ion radiotherapy with concurrent gemcitabine (GEM)in patients with locally advanced pancreatic cancer. Fifty-three patients received carbon ion radiotherapy with a total dose of 43.2-50.4 GyE in 12 fractions and concurrent GEM with a dose of 400-1000mg/m2 once a week. The correlation between GI toxicities and dose-volume histogram (DVH) parameters in stomach and duodenum was analyzed. In patients with gastric ulcer, the total dose irradiated in stomach had tendency to increase. However there was no significant correlation between other GI toxicity and DVH. It was considered that the risk of GI toxicities after carbon ion radiotherapy was too low to correlate with irradiated dose-volume factors.","subitem_description_type":"Abstract"}]},"item_10004_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"放医研"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"篠藤, 誠"}],"nameIdentifiers":[{"nameIdentifier":"571913","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"山田, 滋"}],"nameIdentifiers":[{"nameIdentifier":"571914","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"篠藤 誠","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"571915","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"山田 滋","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"571916","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"局所進行膵癌に対するゲムシタビン併用炭素イオン線治療における消化管有害反応のDVH解析","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"局所進行膵癌に対するゲムシタビン併用炭素イオン線治療における消化管有害反応のDVH解析"}]},"item_type_id":"10004","owner":"1","path":["7"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-11-18"},"publish_date":"2013-11-18","publish_status":"0","recid":"55889","relation_version_is_last":true,"title":["局所進行膵癌に対するゲムシタビン併用炭素イオン線治療における消化管有害反応のDVH解析"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T22:44:13.028352+00:00"}